Asahi Glass Company, Limited

Murata Manufacturing Co., Ltd.

Fujitsu Corporation

Takeda Pharmaceutical Company Limited

Sony Corporation

Kabushiki Kaisha Toshiba

Ricoh Company, Ltd.

Renesas Electronics Corporation

Other

Canon Kabushiki Kaisha

Renesas Technology Corp.

Sony Semiconductor Solutions Corporation

Sato Pharmaceutical Co., Ltd.

Tdk Corporation

Nec Electronics Corporation

Masahiro Ito

Takashi Okazoe

Kunio Watanabe

Kiichiro Takenaka

Daisuke Shirakawa

Hidetoshi Matsumoto

Tsuyoshi Sato

Shin Tatematsu

Satoshi Tanaka

Hideyuki Sugiyama

Satoshi Arayashiki

Isamu Kaneko

Eisuke Murotani

Keiko Kakegawa

Kimiaki Kashiwagi

Shu-zhong Wang

Takeshi Yamamoto

Yasuo Inoue

Masato Yoshikawa

Ken Kikuchi

Hideto Mori

Yasuyoshi Arikawa

Hironobu Maezaki

Hayato Nakamura

Yasuhiro Imaeda

Mitsuo Ariie

Akinori Toita

Hironori Kokubo

Hidehiko Shidara

Masakazu Hori

Tsutomu Chou

Taizo Yamawaki

Masatoshi Hase

Noboru Murayama

Taiki Hoshino

Masao Shigeta

Takahito Kasahara

Shohei Mimura

Junsi Wang

Jinxing Li

Koji Ono

Hidekazu Okamoto

Koji Masuda

Toshio Tanaka

Kazuya Oharu

Hirokazu Takagi

Atsushi Watakabe

Takuto Kojima

Hidekazu Tokuhara

Hiroshi Banno

Masao Iwaya

Tomohiro Okawa

Takashi Soga

Minoru Sasaki

Yasutomi Asano

Takaharu Hirayama

Takeshi Eriguchi

Tohru Miyazaki

Ayumu Sato

Jinichi Yonemori

Yasuhiro Hirata

Fumiaki Kikuchi

Takeya Meguro

Nobuki Sakauchi

Kozo Sato

Kei Sato

Hitoshi Isobe

Misaki Homma

Toyo Osumi

Nobuo Cho

Moriteru Asano

Ryo Mizojiri

Douglas Robert Cary

Jun Fujimoto

Osamu Kubo

Nao Morishita

Kiyotaka Matsui

Masami Inuma

Tsutomu Sato

Koichi Suzuki

Hiroaki Unno

Akira Matsui

Kazuyuki Shimada

Hidenori Obiya

Nobuo Sakuma

Kazuhiko Inoue

Chikara Ishizaka

Masumi Kasahara

Yasushi Sato

Hiroyuki Kinoshita

Hirokatsu Suzuki

Hiroaki Matsui

Shinya Hitomi

Muhammad Siddiqui

Yukinori Akamine

Kenji Iwata

Takashi Murakami

Tomohiro Yamasaki

Provided is a compound that may have a superior CDK12 inhibitory action and is expected to be useful as a prophylactic or therapeutic drug for cancer and the like. A compound represented by the following formula (I):

Nitrogen containing heterocycles as CDK12 inhibitors

The present invention provides a heterocyclic compound having a HDAC6 inhibitory action, which is useful for the treatment of central nervous system diseases including neurodegenerative diseases, and the like, and a medicament comprising the compound. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof.

Heterocyclic compound

Provided is an information processing apparatus including a first acquisition unit, a second acquisition unit, and an estimation unit. The first acquisition unit acquires first sensing information obtained by capturing an image of a subject using a first sensor including a single-plate image sensor. The second acquisition unit acquires second sensing information obtained by sensing a direction different from a direction of the first sensor using second sensor. The estimation unit estimates the spectral reflectance of the subject based on the first sensing information and the second sensing information.

Information processing apparatus, imaging system, and information processing method

A radio frequency signal having a constant amplitude is modulated by a digital modulation signal and a radio frequency input signal whose amplitude changes stepwise is generated. The radio frequency input signal is input into a power amplifier that is an evaluation target. A period in which an amplitude of the radio frequency input signal is constant is defined as a measurement period and an output signal of the power amplifier is measured in each of measurement periods in which amplitudes of the radio frequency input signal are different from each other.

Power amplifier evaluation method and measurement system

The present invention provides a heterocyclic compound having a HDAC inhibitory action, which is useful for the treatment of central nervous system diseases including neurodegenerative diseases, and the like, and a medicament comprising the compound. The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the description, or a salt thereof.

According to an embodiment, an information processing apparatus includes one or more processors. The one or more processors display a relation display screen including text box images each indicating one of a plurality of text ranges included in a document and a relation image indicating a relation between the plurality of text ranges.

Information processing apparatus, information processing method, and information processing system

The present invention provides a technique that allows a pharmaceutical composition, preferably for external use, containing luliconazole or the like to contain luliconazole or the like at a high concentration, and suppresses the precipitation thereof over time. The present invention uses a polyethylene glycol having an average molecular weight of 380 to 420 represented by a formula HOCH(CHOCH)CHOH (where n is an integer), ethanol, benzyl alcohol, lactic acid, propylene carbonate, and acetone in combination with the luliconazole or the like.

Pharmaceutical composition containing antifungal agent as active ingredient

Provided is a compound that may have a superior CDK12 inhibitory action and is expected to be useful as a prophylactic or therapeutic drug for cancer and the like. A compound represented by the following formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof.

A matching network is a matching network of a power amplifier circuit that outputs a signal obtained by a differential amplifier amplifying power of a high-frequency signal. The matching network includes an input-side winding connected between differential outputs of the differential amplifier; an output-side winding that is coupled to the input-side winding via an electromagnetic field and whose one end is connected to a reference potential; a first LC series resonant circuit including a capacitive element and an inductive element connected in series with each other, and being connected in parallel with the input-side winding; and a second LC series resonant circuit including a capacitive element and an inductive element connected in series with each other, and being connected in parallel with the output-side winding.

Matching network and power amplifier circuit

A transceiver module according to an embodiment of the present disclosure includes a power amplifier, a first transformer, a low-noise amplifier, and a second transformer. The power amplifier amplifies a transmission signal for outputting to an antenna terminal. The first transformer includes a first winding and a second winding. The first winding is connected to the antenna terminal, and the second winding is connected to an output side of the power amplifier. The low-noise amplifier amplifies a reception signal inputted through the antenna terminal. The second transformer includes the first winding and a third winding connected to an input side of the low-noise amplifier.

Transceiver module

A high-frequency front-end circuit includes a plurality of power amplifiers. Power supply inductors and matching inductors for the power amplifiers are formed of conductors disposed on a substrate. The power supply inductors and the matching inductors are disposed on or in different layers. When the substrate is seen in a plan view, at least a portion of the first power supply inductor and at least a portion of the second matching inductor overlap each other with an insulating layer interposed therebetween.

High-frequency front-end circuit

Growing community of inventors

Kanagawa, Japan

Masahiro Ito